会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Novel mammalian catecholamine receptor genes and uses
    • 新型哺乳动物儿茶酚胺受体基因及用途
    • US20040142390A1
    • 2004-07-22
    • US10769131
    • 2004-01-30
    • Oregon Health Sciences University, a non-profit organization
    • James R. BunzowDavid K. Grandy
    • G01N033/53G01N033/567C07H021/04C07K014/705
    • C07K14/723A61K38/00
    • The present invention relates to novel mammalian catecholamine receptor proteins and genes that encode such proteins. The invention is directed toward the isolation and characterization of mammalian catecholamine receptor proteins. The invention specifically provides isolated complementary DNA copies of mRNA corresponding to rat and human homologues of a mammalian catecholamine receptor gene. Also provided are recombinant expression constructs capable of expressing the mammalian catecholamine receptor genes of the invention in cultures of transformed prokaryotic and eukaryotic cells, as well as such cultures of transformed cells that synthesize the mammalian catecholamine receptor proteins encoded therein. The invention also provides methods for screening compounds in vitro that are capable of binding to the mammalian catecholamine receptor proteins of the invention, and further characterizing the binding properties of such compounds in comparison with known catecholamine receptor agonists and antagonists. Improved methods of pharmacological screening are provided thereby.
    • 本发明涉及新型的哺乳动物儿茶酚胺受体蛋白质和编码这种蛋白质的基因。 本发明涉及哺乳动物儿茶酚胺受体蛋白的分离和表征。 本发明特别提供了与哺乳动物儿茶酚胺受体基因的大鼠和人类同源物相对应的mRNA的分离的互补DNA拷贝。 还提供了能够在转化的原核和真核细胞的培养物中表达本发明的哺乳动物儿茶酚胺受体基因以及合成其中编码的哺乳动物儿茶酚胺受体蛋白质的转化细胞的这种培养物的重组表达构建体。 本发明还提供了在体外筛选能够结合本发明的哺乳动物儿茶酚胺受体蛋白的方法,并且与已知的儿茶酚胺受体激动剂和拮抗剂相比进一步表征了这些化合物的结合性质。 从而提供改进的药理学筛选方法。